Silo Pharma, Inc. entered into securities purchase agreements with accredited investors for a private placement closing on November 6, 2026. The company issued 136,005 shares of common stock at $1.50 per share and pre-funded warrants to purchase up to 430,661 additional shares at $1.4999 per warrant. Net proceeds are expected to be approximately $815,000 after deducting fees and expenses. The company intends to use the funds for working capital and general corporate purposes. Silo Pharma operates in the pharmaceutical industry.
